State
19,713 recalls have nationwide distribution and so reach New Hampshire. 0 additional recalls listed New Hampshire specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect New Hampshire consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: FDA_DEVICE Z-1398-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1371-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1363-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1367-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1375-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1409-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1421-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1403-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1380-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0510-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1378-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1422-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1392-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1407-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1381-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1424-2026.
Pending LLM rewrite. Source: CPSC 26287.
Pending LLM rewrite. Source: CPSC 26275.
Pending LLM rewrite. Source: CPSC 26273.
Pending LLM rewrite. Source: CPSC 26272.
Pending LLM rewrite. Source: CPSC 26274.
Pending LLM rewrite. Source: CPSC 26277.
Pending LLM rewrite. Source: CPSC 26276.
Pending LLM rewrite. Source: CPSC 26271.
Pending LLM rewrite. Source: FDA_DRUG D-0309-2026.